25 XP   0   0   10

Baudax Bio Inc
Buy, Hold or Sell?

Let's analyse Baudax Bio Inc together

PenkeI guess you are interested in Baudax Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Baudax Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Baudax Bio Inc

I send you an email if I find something interesting about Baudax Bio Inc.

Quick analysis of Baudax Bio Inc (30 sec.)










What can you expect buying and holding a share of Baudax Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$-0.23
Expected worth in 1 year
$-0.02
How sure are you?
45.0%

+ What do you gain per year?

Total Gains per Share
$0.21
Return On Investment
1,641.4%

For what price can you sell your share?

Current Price per Share
$0.01
Expected price per share
$0.012 - $0.0205
How sure are you?
50%

1. Valuation of Baudax Bio Inc (5 min.)




Live pricePrice per Share (EOD)

$0.01

Intrinsic Value Per Share

$4.45 - $5.71

Total Value Per Share

$4.21 - $5.47

2. Growth of Baudax Bio Inc (5 min.)




Is Baudax Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$10.2m$1.9m-$15m-114.6%

How much money is Baudax Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.7m-$5m$3.2m181.1%
Net Profit Margin-27,256.0%-2,614.5%--

How much money comes from the company's main activities?

3. Financial Health of Baudax Bio Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#962 / 1031

Most Revenue
#639 / 1031

Most Profit
#305 / 1031

Most Efficient
#991 / 1031

What can you expect buying and holding a share of Baudax Bio Inc? (5 min.)

Welcome investor! Baudax Bio Inc's management wants to use your money to grow the business. In return you get a share of Baudax Bio Inc.

What can you expect buying and holding a share of Baudax Bio Inc?

First you should know what it really means to hold a share of Baudax Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Baudax Bio Inc is $0.013. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Baudax Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Baudax Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.23. Based on the TTM, the Book Value Change Per Share is $0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Baudax Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.04-341.3%-0.15-1,144.1%-0.10-780.3%-0.25-1,924.8%-0.25-1,924.8%
Usd Book Value Change Per Share0.0177.8%0.05410.4%0.0152.4%-0.01-90.3%-0.01-90.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.0177.8%0.05410.4%0.0152.5%-0.01-90.3%-0.01-90.3%
Usd Price Per Share0.37-1.61-0.77-1.47-1.47-
Price to Earnings Ratio-2.08--2.52--0.69--1.25--1.25-
Price-to-Total Gains Ratio36.57--0.92--7.26--1.67--1.67-
Price to Book Ratio-1.58--5.55-4.20--5.01--5.01-
Price-to-Total Gains Ratio36.57--0.92--7.26--1.67--1.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.013
Number of shares76923
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.05-0.01
Usd Total Gains Per Share0.05-0.01
Gains per Quarter (76923 shares)4,103.50-903.19
Gains per Year (76923 shares)16,414.01-3,612.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1016414164040-3613-3623
2032828328181-7226-7236
3049242492321-10839-10849
4065656656461-14453-14462
5082070820602-18066-18075
6098484984742-21679-21688
701148981148882-25292-25301
801313121313023-28905-28914
901477261477163-32518-32527
1001641401641304-36131-36140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%2.018.00.010.0%2.018.00.010.0%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%9.011.00.045.0%9.011.00.045.0%9.011.00.045.0%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.019.05.0%1.00.019.05.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%9.011.00.045.0%9.011.00.045.0%9.011.00.045.0%

Fundamentals of Baudax Bio Inc

About Baudax Bio Inc

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.

Fundamental data was last updated by Penke on 2024-03-20 12:25:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Baudax Bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Baudax Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Baudax Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Baudax Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-27,256.0%+27,256.0%
TTM-27,256.0%YOY-2,614.5%-24,641.5%
TTM-27,256.0%5Y-7,782.5%-19,473.5%
5Y-7,782.5%10Y-7,782.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM-27,256.0%-202.3%-27,053.7%
YOY-2,614.5%-263.0%-2,351.5%
5Y-7,782.5%-452.4%-7,330.1%
10Y-7,782.5%-589.0%-7,193.5%
1.1.2. Return on Assets

Shows how efficient Baudax Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Baudax Bio Inc to the Biotechnology industry mean.
  • -9.4% Return on Assets means that Baudax Bio Inc generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Baudax Bio Inc:

  • The MRQ is -9.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 6.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM6.3%-15.7%
TTM6.3%YOY-39.1%+45.4%
TTM6.3%5Y-21.6%+27.9%
5Y-21.6%10Y-21.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.4%-12.5%+3.1%
TTM6.3%-12.2%+18.5%
YOY-39.1%-11.2%-27.9%
5Y-21.6%-13.3%-8.3%
10Y-21.6%-14.6%-7.0%
1.1.3. Return on Equity

Shows how efficient Baudax Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Baudax Bio Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Baudax Bio Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Baudax Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-21.7%+21.7%
TTM-5Y-4.3%+4.3%
5Y-4.3%10Y-4.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.0%+16.0%
TTM--15.8%+15.8%
YOY-21.7%-13.9%-7.8%
5Y-4.3%-18.2%+13.9%
10Y-4.3%-19.1%+14.8%

1.2. Operating Efficiency of Baudax Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Baudax Bio Inc is operating .

  • Measures how much profit Baudax Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Baudax Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Baudax Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6,827.0%-6,827.0%
TTM6,827.0%YOY-388.3%+7,215.3%
TTM6,827.0%5Y-4,792.9%+11,620.0%
5Y-4,792.9%10Y-4,792.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM6,827.0%-208.5%+7,035.5%
YOY-388.3%-280.2%-108.1%
5Y-4,792.9%-459.9%-4,333.0%
10Y-4,792.9%-596.9%-4,196.0%
1.2.2. Operating Ratio

Measures how efficient Baudax Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Baudax Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-50.030+50.030
TTM-50.030YOY29.804-79.835
TTM-50.0305Y28.822-78.852
5Y28.82210Y28.8220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-50.0303.181-53.211
YOY29.8043.609+26.195
5Y28.8225.554+23.268
10Y28.8227.396+21.426

1.3. Liquidity of Baudax Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Baudax Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.07 means the company has $0.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Baudax Bio Inc:

  • The MRQ is 0.070. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.197. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.070TTM0.197-0.127
TTM0.197YOY0.921-0.724
TTM0.1975Y1.225-1.027
5Y1.22510Y1.2250.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0703.987-3.917
TTM0.1974.440-4.243
YOY0.9215.569-4.648
5Y1.2256.158-4.933
10Y1.2256.492-5.267
1.3.2. Quick Ratio

Measures if Baudax Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Baudax Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.02 means the company can pay off $0.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Baudax Bio Inc:

  • The MRQ is 0.019. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.164. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.019TTM0.164-0.145
TTM0.164YOY0.561-0.397
TTM0.1645Y1.073-0.908
5Y1.07310Y1.0730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0193.653-3.634
TTM0.1644.158-3.994
YOY0.5615.515-4.954
5Y1.0736.012-4.939
10Y1.0736.206-5.133

1.4. Solvency of Baudax Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Baudax Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Baudax Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.50 means that Baudax Bio Inc assets are financed with 149.7% credit (debt) and the remaining percentage (100% - 149.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Baudax Bio Inc:

  • The MRQ is 1.497. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.112. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.497TTM2.112-0.615
TTM2.112YOY1.141+0.971
TTM2.1125Y1.652+0.460
5Y1.65210Y1.6520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4970.336+1.161
TTM2.1120.330+1.782
YOY1.1410.267+0.874
5Y1.6520.367+1.285
10Y1.6520.378+1.274
1.4.2. Debt to Equity Ratio

Measures if Baudax Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Baudax Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Baudax Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.923-3.923
TTM-5Y0.785-0.785
5Y0.78510Y0.7850.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.376-0.376
TTM-0.398-0.398
YOY3.9230.334+3.589
5Y0.7850.431+0.354
10Y0.7850.476+0.309

2. Market Valuation of Baudax Bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Baudax Bio Inc generates.

  • Above 15 is considered overpriced but always compare Baudax Bio Inc to the Biotechnology industry mean.
  • A PE ratio of -2.08 means the investor is paying $-2.08 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Baudax Bio Inc:

  • The EOD is -0.073. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.085. Based on the earnings, the company is expensive. -2
  • The TTM is -2.518. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.073MRQ-2.085+2.012
MRQ-2.085TTM-2.518+0.433
TTM-2.518YOY-0.687-1.831
TTM-2.5185Y-1.254-1.264
5Y-1.25410Y-1.2540.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.073-2.697+2.624
MRQ-2.085-2.422+0.337
TTM-2.518-2.709+0.191
YOY-0.687-4.116+3.429
5Y-1.254-6.257+5.003
10Y-1.254-6.478+5.224
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Baudax Bio Inc:

  • The EOD is -0.059. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.671. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.651. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.059MRQ-1.671+1.612
MRQ-1.671TTM-4.651+2.980
TTM-4.651YOY-0.910-3.741
TTM-4.6515Y-2.310-2.341
5Y-2.31010Y-2.3100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.059-3.344+3.285
MRQ-1.671-2.939+1.268
TTM-4.651-3.486-1.165
YOY-0.910-5.592+4.682
5Y-2.310-8.464+6.154
10Y-2.310-8.872+6.562
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Baudax Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -1.58 means the investor is paying $-1.58 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Baudax Bio Inc:

  • The EOD is -0.055. Based on the equity, the company is expensive. -2
  • The MRQ is -1.575. Based on the equity, the company is expensive. -2
  • The TTM is -5.551. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.055MRQ-1.575+1.520
MRQ-1.575TTM-5.551+3.975
TTM-5.551YOY4.205-9.756
TTM-5.5515Y-5.012-0.539
5Y-5.01210Y-5.0120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0552.198-2.253
MRQ-1.5752.042-3.617
TTM-5.5512.121-7.672
YOY4.2052.907+1.298
5Y-5.0123.682-8.694
10Y-5.0124.114-9.126
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Baudax Bio Inc.

3.1. Institutions holding Baudax Bio Inc

Institutions are holding 2.676% of the shares of Baudax Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Creative Planning Inc000-45001-100
2023-12-31State Street Corporation000-11602-100
2023-12-31Susquehanna International Group, LLP000-10699-100
2023-12-31Wells Fargo & Co000-53-100
2023-09-30JANE STREET GROUP, LLC000-27342-100
2023-12-31Tower Research Capital LLC000-10834-100
2023-12-31UBS Group AG000-6844-100
2023-12-31Group One Trading, LP000-4-100
2023-09-30Morgan Stanley - Brokerage Accounts000-1-100
2023-12-31Vanguard Group Inc000-48300-100
2023-12-31Geode Capital Management, LLC000-45363-100
2023-12-31Virtu Financial LLC000-41888-100
2023-09-30SITTNER & NELSON, LLC000-1-100
2023-12-31BlackRock Inc000-797-100
2023-12-31Advisor Group Holdings, Inc.000-22-100
2023-12-31XTX Topco Ltd000-23426-100
Total 000-272177-100

3.2. Funds holding Baudax Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-11-16iShares Core S&P Total US Stock Mkt ETF00220
2023-09-30NT Quality SCC US Fund - L00100
2023-09-30NT Quality Small Cap Core00100
Total 004+2+50.0%

3.3. Insider Transactions

Insiders are holding 0.017% of the shares of Baudax Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-12-15Geraldine HenwoodBUY12002.55
2021-09-22Geraldine HenwoodBUY20523.6
2021-08-31Winston J ChurchillBUY250025.2
2021-08-20Richard S CastenBUY125020.4
2021-05-14Richard S CastenBUY62531.6
2021-05-11Arnold M BaskiesBUY25032.8
2021-05-07Geraldine HenwoodBUY15033.2

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Baudax Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0100.053-81%0.007+48%-0.012+216%-0.012+216%
Book Value Per Share---0.235-0.301+28%0.044-635%-0.490+109%-0.490+109%
Current Ratio--0.0700.197-64%0.921-92%1.225-94%1.225-94%
Debt To Asset Ratio--1.4972.112-29%1.141+31%1.652-9%1.652-9%
Debt To Equity Ratio----0%3.923-100%0.785-100%0.785-100%
Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Eps---0.044-0.149+235%-0.101+129%-0.250+464%-0.250+464%
Free Cash Flow Per Share---0.055-0.082+48%-0.211+282%-0.227+310%-0.227+310%
Free Cash Flow To Equity Per Share---0.024-0.031+30%-0.111+368%0.000-5286%0.000-5286%
Gross Profit Margin--1.0001.0000%1.0000%1.007-1%1.007-1%
Intrinsic Value_10Y_max--5.706--------
Intrinsic Value_10Y_min--4.449--------
Intrinsic Value_1Y_max---0.590--------
Intrinsic Value_1Y_min---0.580--------
Intrinsic Value_3Y_max---0.888--------
Intrinsic Value_3Y_min---0.865--------
Intrinsic Value_5Y_max---0.117--------
Intrinsic Value_5Y_min---0.185--------
Market Cap566710.300-2746%16129447.00069966925.500-77%33598291.998-52%64229419.644-75%64229419.644-75%
Net Profit Margin----272.5600%-26.1450%-77.8250%-77.8250%
Operating Margin---68.270-100%-3.8830%-47.9290%-47.9290%
Operating Ratio----50.0300%29.804-100%28.822-100%28.822-100%
Pb Ratio-0.055+96%-1.575-5.551+252%4.205-137%-5.012+218%-5.012+218%
Pe Ratio-0.073+96%-2.085-2.518+21%-0.687-67%-1.254-40%-1.254-40%
Price Per Share0.013-2746%0.3701.605-77%0.771-52%1.473-75%1.473-75%
Price To Free Cash Flow Ratio-0.059+96%-1.671-4.651+178%-0.910-46%-2.310+38%-2.310+38%
Price To Total Gains Ratio1.285-2746%36.575-0.921+103%-7.258+120%-1.666+105%-1.666+105%
Quick Ratio--0.0190.164-88%0.561-97%1.073-98%1.073-98%
Return On Assets---0.0940.063-249%-0.391+316%-0.216+130%-0.216+130%
Return On Equity----0%-0.2170%-0.0430%-0.0430%
Total Gains Per Share--0.0100.053-81%0.007+48%-0.012+216%-0.012+216%
Usd Book Value---10238000.000-13118000.000+28%1914750.000-635%-21372150.000+109%-21372150.000+109%
Usd Book Value Change Per Share--0.0100.053-81%0.007+48%-0.012+216%-0.012+216%
Usd Book Value Per Share---0.235-0.301+28%0.044-635%-0.490+109%-0.490+109%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Usd Eps---0.044-0.149+235%-0.101+129%-0.250+464%-0.250+464%
Usd Free Cash Flow---2413000.000-3566500.000+48%-9210750.000+282%-9901200.000+310%-9901200.000+310%
Usd Free Cash Flow Per Share---0.055-0.082+48%-0.211+282%-0.227+310%-0.227+310%
Usd Free Cash Flow To Equity Per Share---0.024-0.031+30%-0.111+368%0.000-5286%0.000-5286%
Usd Market Cap566710.300-2746%16129447.00069966925.500-77%33598291.998-52%64229419.644-75%64229419.644-75%
Usd Price Per Share0.013-2746%0.3701.605-77%0.771-52%1.473-75%1.473-75%
Usd Profit---1934000.000-1788500.000-8%-5027750.000+160%-10090300.000+422%-10090300.000+422%
Usd Revenue---81500.000-100%340000.000-100%142950.000-100%142950.000-100%
Usd Total Gains Per Share--0.0100.053-81%0.007+48%-0.012+216%-0.012+216%
 EOD+1 -7MRQTTM+13 -16YOY+20 -125Y+20 -1310Y+20 -13

4.2. Fundamental Score

Let's check the fundamental score of Baudax Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.073
Price to Book Ratio (EOD)Between0-1-0.055
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.019
Current Ratio (MRQ)Greater than10.070
Debt to Asset Ratio (MRQ)Less than11.497
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.094
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Baudax Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.109
Ma 20Greater thanMa 500.016
Ma 50Greater thanMa 1000.021
Ma 100Greater thanMa 2000.045
OpenGreater thanClose0.016
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Total Other Income Expense Net -45,76745,118-649-2,049-2,698-570-3,2686,9173,649



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets20,583
Total Liabilities30,821
Total Stockholder Equity-10,238
 As reported
Total Liabilities 30,821
Total Stockholder Equity+ -10,238
Total Assets = 20,583

Assets

Total Assets20,583
Total Current Assets1,338
Long-term Assets19,245
Total Current Assets
Cash And Cash Equivalents 363
Other Current Assets 975
Total Current Assets  (as reported)1,338
Total Current Assets  (calculated)1,338
+/-0
Long-term Assets
Property Plant Equipment 6,548
Goodwill 8,797
Intangible Assets 3,900
Long-term Assets  (as reported)19,245
Long-term Assets  (calculated)19,245
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities19,051
Long-term Liabilities11,770
Total Stockholder Equity-10,238
Total Current Liabilities
Short-term Debt 5,569
Short Long Term Debt 5,228
Accounts payable 7,822
Other Current Liabilities 2,132
Total Current Liabilities  (as reported)19,051
Total Current Liabilities  (calculated)20,751
+/- 1,700
Long-term Liabilities
Capital Lease Obligations 2,869
Long-term Liabilities  (as reported)11,770
Long-term Liabilities  (calculated)2,869
+/- 8,901
Total Stockholder Equity
Common Stock122
Retained Earnings -189,300
Other Stockholders Equity 178,940
Total Stockholder Equity (as reported)-10,238
Total Stockholder Equity (calculated)-10,238
+/-0
Other
Capital Stock122
Cash and Short Term Investments 363
Common Stock Shares Outstanding 7,994
Current Deferred Revenue3,528
Liabilities and Stockholders Equity 20,583
Net Debt 7,734
Net Invested Capital -5,010
Net Working Capital -17,713
Property Plant and Equipment Gross 7,067
Short Long Term Debt Total 8,097



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
> Total Assets 
0
35,023
37,031
38,147
35,985
54,213
74,154
75,487
61,467
68,733
74,986
73,808
61,499
53,277
48,813
40,834
17,510
10,032
7,065
21,316
20,583
20,58321,3167,06510,03217,51040,83448,81353,27761,49973,80874,98668,73361,46775,48774,15454,21335,98538,14737,03135,0230
   > Total Current Assets 
0
2,514
2,659
3,586
1,658
20,135
40,495
42,667
28,955
36,717
43,690
43,281
31,138
23,494
19,716
12,479
11,269
6,347
4,108
1,860
1,338
1,3381,8604,1086,34711,26912,47919,71623,49431,13843,28143,69036,71728,95542,66740,49520,1351,6583,5862,6592,5140
       Cash And Cash Equivalents 
0
0
0
0
0
17,740
38,284
39,410
24,608
30,342
30,690
25,412
14,772
15,891
11,527
5,210
5,647
5,259
3,803
1,416
363
3631,4163,8035,2595,6475,21011,52715,89114,77225,41230,69030,34224,60839,41038,28417,74000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
7,495
12,147
10,150
0
0
0
0
0
0
0
0
0000000010,15012,1477,4950000000000
       Net Receivables 
0
0
0
0
0
0
0
382
0
51
163
219
422
542
608
616
313
335
0
0
0
0003353136166085424222191635103820000000
       Other Current Assets 
0
2,514
0
3,586
1,658
2,395
2,211
2,122
2,563
3,346
2,569
1,945
1,484
2,059
2,369
1,398
832
753
305
444
975
9754443057538321,3982,3692,0591,4841,9452,5693,3462,5632,1222,2112,3951,6583,58602,5140
   > Long-term Assets 
0
32,509
0
34,561
34,327
34,078
33,659
32,820
32,512
32,016
31,296
30,527
30,361
29,783
29,097
28,355
6,241
3,685
2,957
19,456
19,245
19,24519,4562,9573,6856,24128,35529,09729,78330,36130,52731,29632,01632,51232,82033,65934,07834,32734,561032,5090
       Property Plant Equipment 
0
3,982
5,845
6,034
5,800
5,551
5,347
5,152
5,487
5,635
5,039
4,979
4,933
5,015
4,992
4,941
1,239
704
1
6,720
6,548
6,5486,72017041,2394,9414,9925,0154,9334,9795,0395,6355,4875,1525,3475,5515,8006,0345,8453,9820
       Goodwill 
0
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
2,127
9,236
8,797
8,7979,2362,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1270
       Intangible Assets 
0
26,400
26,400
26,400
26,400
26,400
26,185
25,541
24,898
24,254
23,610
22,966
22,322
21,678
21,034
20,390
2,000
0
0
3,500
3,900
3,9003,500002,00020,39021,03421,67822,32222,96623,61024,25424,89825,54126,18526,40026,40026,40026,40026,4000
       Other Assets 
0
0
0
0
0
0
0
0
652
0
520
455
979
963
944
897
875
854
0
0
0
000854875897944963979455520065200000000
> Total Liabilities 
0
103,370
88,363
67,334
71,408
70,934
110,046
134,891
106,697
83,532
75,980
78,381
82,227
40,051
39,070
36,604
37,050
34,274
14,378
31,995
30,821
30,82131,99514,37834,27437,05036,60439,07040,05182,22778,38175,98083,532106,697134,891110,04670,93471,40867,33488,363103,3700
   > Total Current Liabilities 
0
22,780
22,108
4,985
5,217
7,713
18,705
20,153
19,922
18,129
14,123
13,822
14,442
15,646
20,397
18,181
21,275
21,460
12,371
20,457
19,051
19,05120,45712,37121,46021,27518,18120,39715,64614,44213,82214,12318,12919,92220,15318,7057,7135,2174,98522,10822,7800
       Short-term Debt 
0
0
0
0
356
318
278
856
171
1,016
1,196
555
1,389
2,222
3,056
3,611
5,911
5,600
6,000
6,475
5,569
5,5696,4756,0005,6005,9113,6113,0562,2221,3895551,1961,0161718562783183560000
       Short Long Term Debt 
0
0
0
0
0
0
0
598
171
683
1,196
555
1,389
2,222
3,056
3,611
5,911
5,600
6,000
5,861
5,228
5,2285,8616,0005,6005,9113,6113,0562,2221,3895551,1966831715980000000
       Accounts payable 
0
2,653
9,506
352
361
271
2,062
2,190
1,782
3,653
1,140
2,085
1,819
1,468
3,284
3,064
3,609
3,927
3,837
5,828
7,822
7,8225,8283,8373,9273,6093,0643,2841,4681,8192,0851,1403,6531,7822,1902,0622713613529,5062,6530
       Other Current Liabilities 
0
20,127
6,778
4,633
4,500
7,124
16,365
17,107
17,969
13,460
11,787
11,182
11,234
11,956
14,057
11,506
11,755
11,933
2,534
5,667
2,132
2,1325,6672,53411,93311,75511,50614,05711,95611,23411,18211,78713,46017,96917,10716,3657,1244,5004,6336,77820,1270
   > Long-term Liabilities 
0
80,590
0
62,349
66,191
63,221
91,341
114,738
86,775
65,403
61,857
64,559
67,785
24,405
18,673
18,423
15,775
12,814
2,007
11,538
11,770
11,77011,5382,00712,81415,77518,42318,67324,40567,78564,55961,85765,40386,775114,73891,34163,22166,19162,349080,5900
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
8,469
8,185
7,518
0
0
0
0
0
0
0
0
0
0000000007,5188,1858,469000000000
       Other Liabilities 
0
0
65,586
61,762
65,671
62,766
90,950
106,312
77,661
56,641
53,672
56,798
60,872
18,096
12,339
13,324
13,600
10,697
0
202
0
0202010,69713,60013,32412,33918,09660,87256,79853,67256,64177,661106,31290,95062,76665,67161,76265,58600
> Total Stockholder Equity
0
-68,347
-51,332
-29,187
-35,423
-16,721
-35,892
-59,404
-45,230
-14,799
-994
-4,573
-20,728
13,226
9,743
4,230
-19,540
-24,242
-7,313
-10,679
-10,238
-10,238-10,679-7,313-24,242-19,5404,2309,74313,226-20,728-4,573-994-14,799-45,230-59,404-35,892-16,721-35,423-29,187-51,332-68,3470
   Common Stock
0
0
-51,332
-29,187
-35,423
94
176
184
184
487
701
843
844
983
64
81
200
16
26
70
122
122702616200816498384484370148718418417694-35,423-29,187-51,33200
   Retained Earnings Total Equity000000000-144,561-129,232-112,320000000000
   Accumulated Other Comprehensive Income -9,040-9,04000000000-1,334-1,248-1,155-1,051-945-840-808-6910-4720
   Capital Surplus 
0
0
0
0
0
19,405
40,450
0
0
97,034
127,537
139,145
0
0
0
0
0
0
0
0
0
000000000139,145127,53797,0340040,45019,40500000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
-67,875
0
-28,496
-34,615
20,245
41,395
48,426
51,019
98,282
128,871
139,145
139,951
144,332
154,577
156,578
161,914
166,646
172,161
176,126
178,940
178,940176,126172,161166,646161,914156,578154,577144,332139,951139,145128,87198,28251,01948,42641,39520,245-34,615-28,4960-67,8750



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,269
Cost of Revenue--
Gross Profit-1,269
 
Operating Income (+$)
Gross Profit-
Operating Expense-36,292
Operating Income-35,023-36,292
 
Operating Expense (+$)
Research Development8,288
Selling General Administrative18,998
Selling And Marketing Expenses-
Operating Expense36,29227,286
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-35,023
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-58,747-11,299
EBIT - interestExpense = 0
-7,154
-7,154
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--58,747
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-58,747
Tax Provision--
Net Income From Continuing Ops-58,747-58,747
Net Income-7,154
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-23,7240
 

Technical Analysis of Baudax Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Baudax Bio Inc. The general trend of Baudax Bio Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Baudax Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Baudax Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.0145 < 0.02 < 0.0205.

The bearish price targets are: 0.012 > 0.012.

Tweet this
Baudax Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Baudax Bio Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Baudax Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Baudax Bio Inc. The current macd is -0.00216985.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Baudax Bio Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Baudax Bio Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Baudax Bio Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Baudax Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartBaudax Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Baudax Bio Inc. The current adx is 17.60.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Baudax Bio Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Baudax Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Baudax Bio Inc. The current sar is 0.0122.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Baudax Bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Baudax Bio Inc. The current rsi is 40.11. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Baudax Bio Inc Daily Relative Strength Index (RSI) ChartBaudax Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Baudax Bio Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Baudax Bio Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Baudax Bio Inc Daily Stochastic Oscillator ChartBaudax Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Baudax Bio Inc. The current cci is -132.66021596.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Baudax Bio Inc Daily Commodity Channel Index (CCI) ChartBaudax Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Baudax Bio Inc. The current cmo is -20.01275711.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Baudax Bio Inc Daily Chande Momentum Oscillator (CMO) ChartBaudax Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Baudax Bio Inc. The current willr is -88.23529412.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Baudax Bio Inc Daily Williams %R ChartBaudax Bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Baudax Bio Inc.

Baudax Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Baudax Bio Inc. The current atr is 0.00472364.

Baudax Bio Inc Daily Average True Range (ATR) ChartBaudax Bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Baudax Bio Inc. The current obv is 411,086,372.

Baudax Bio Inc Daily On-Balance Volume (OBV) ChartBaudax Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Baudax Bio Inc. The current mfi is 43.57.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Baudax Bio Inc Daily Money Flow Index (MFI) ChartBaudax Bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Baudax Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Baudax Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Baudax Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.109
Ma 20Greater thanMa 500.016
Ma 50Greater thanMa 1000.021
Ma 100Greater thanMa 2000.045
OpenGreater thanClose0.016
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Baudax Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Baudax Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Baudax Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Baudax Bio Inc

I send you an email if I find something interesting about Baudax Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Baudax Bio Inc.

Receive notifications about Baudax Bio Inc in your mailbox!